120 related articles for article (PubMed ID: 8852335)
1. Molecular modeling of singlet-oxygen binding to anthraquinones in relation to the peroxidating activity of antitumor anthraquinone drugs.
Liwo A; Jeziorek D; Ossowski T; Dyl D; Tempczyk A; Tarasiuk J; Nowacka M; Borowski E; Woźnicki W
Acta Biochim Pol; 1995; 42(4):445-56. PubMed ID: 8852335
[TBL] [Abstract][Full Text] [Related]
2. A theoretical study of the mechanism of oxygen binding by model anthraquinones. Part II. Quantum-mechanical studies of the energetics of oxygen binding to model anthraquinones.
Jeziorek D; Dyl D; Liwo A; Woźnicki W; Tempczyk A; Borowski E
Anticancer Drug Des; 1993 Jun; 8(3):223-35. PubMed ID: 8517915
[TBL] [Abstract][Full Text] [Related]
3. Enthalpy of oxygen addition to anthraquinone derivatives determines their ability to mediate NADH oxidation.
Jeziorek D; Dyl D; Liwo A; Ossowski T; Woźnicki W
Anticancer Drug Des; 1994 Oct; 9(5):435-48. PubMed ID: 7945727
[TBL] [Abstract][Full Text] [Related]
4. The role of structural factors of anthraquinone compounds and their quinone-modified analogues in NADH dehydrogenase-catalysed oxygen radical formation.
Tarasiuk J; Tkaczyk-Gobis K; Stefañska B; Dzieduszycka M; Priebe W; Martelli S; Borowski E
Anticancer Drug Des; 1998 Dec; 13(8):923-39. PubMed ID: 10335267
[TBL] [Abstract][Full Text] [Related]
5. The direct reduction of cytochrome c by some anthraquinone antitumor compounds.
Tarasiuk J; Stefanska B; Borowski E
Anticancer Drug Des; 1996 Apr; 11(3):183-92. PubMed ID: 8663906
[TBL] [Abstract][Full Text] [Related]
6. An alternative concept for the molecular nature of the peroxidating ability of anthracycline anti-tumor antibiotics and anthracenodiones.
Tempczyk A; Tarasiuk J; Ossowski T; Borowski E
Anticancer Drug Des; 1988 Mar; 2(4):371-85. PubMed ID: 3163250
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of anthraquinone derivatives from Heterophyllaea pustulata (Rubiaceae).
Comini LR; Montoya SC; Páez PL; Argüello GA; Albesa I; Cabrera JL
J Photochem Photobiol B; 2011 Feb; 102(2):108-14. PubMed ID: 20965744
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of singlet oxygen binding by anthraquinones in relation to their redox cycling activity.
Tarasiuk J; Liwo A; Wojtkowiak S; Dzieduszycka M; Tempczyk A; Garnier-Suillerot A; Martelli S; Borowski E
Anticancer Drug Des; 1991 Nov; 6(5):399-416. PubMed ID: 1764163
[TBL] [Abstract][Full Text] [Related]
9. Natural anthraquinones probed as Type I and Type II photosensitizers: singlet oxygen and superoxide anion production.
Montoya SC; Comini LR; Sarmiento M; Becerra C; Albesa I; Argüello GA; Cabrera JL
J Photochem Photobiol B; 2005 Jan; 78(1):77-83. PubMed ID: 15629252
[TBL] [Abstract][Full Text] [Related]
10. A theoretical study of the mechanism of oxygen binding by model anthraquinones. I: Quantum mechanical evaluation of the oxygen-binding sites of 1,4-hydroquinone.
Jeziorek D; Dyl D; Liwo A; Woźnicki W; Tempczyk A; Borowski E
Anticancer Drug Des; 1992 Dec; 7(6):451-61. PubMed ID: 1337429
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of the low activity of antitumor anthracenediones, mitoxantrone and ametantrone, in oxygen radical generation catalyzed by NADH dehydrogenase. Enzymatic and molecular modelling studies.
Tarasiuk J; Mazerski J; Tkaczyk-Gobis K; Borowski E
Eur J Med Chem; 2005 Apr; 40(4):321-8. PubMed ID: 15804531
[TBL] [Abstract][Full Text] [Related]
12. Semiquinone intermediates in the two-electron reduction of quinones in aqueous media and their exceptionally high reactivity towards oxygen reduction.
Li Q; Batchelor-McAuley C; Lawrence NS; Hartshorne RS; Compton RG
Chemphyschem; 2011 May; 12(7):1255-7. PubMed ID: 21506239
[TBL] [Abstract][Full Text] [Related]
13. Study on Redox Properties and Cytotoxicity of Anthraquinone Derivatives to Understand Antitumor Active Anthracycline Substances.
Okumura N; Mizutani H; Ishihama T; Ito M; Hashibe A; Nakayama T; Uno B
Chem Pharm Bull (Tokyo); 2019; 67(7):717-720. PubMed ID: 31257327
[TBL] [Abstract][Full Text] [Related]
14. [Free oxygen radiacals and kidney diseases--part I].
Sakac V; Sakac M
Med Pregl; 2000; 53(9-10):463-74. PubMed ID: 11320727
[TBL] [Abstract][Full Text] [Related]
15. Unifying mechanism for anticancer agents involving electron transfer and oxidative stress: clinical implications.
Kovacic P
Med Hypotheses; 2007; 69(3):510-6. PubMed ID: 17383109
[TBL] [Abstract][Full Text] [Related]
16. Spectroelectrochemistry of the redox activation of anti-cancer drug mitoxantrone.
Enache M; Bendic C; Volanschi E
Bioelectrochemistry; 2008 Feb; 72(1):10-20. PubMed ID: 18068547
[TBL] [Abstract][Full Text] [Related]
17. Photoregulated transmembrane charge separation by linked spiropyran-anthraquinone molecules.
Zhu L; Khairutdinov RF; Cape JL; Hurst JK
J Am Chem Soc; 2006 Jan; 128(3):825-35. PubMed ID: 16417372
[TBL] [Abstract][Full Text] [Related]
18. The reaction of peroxynitrite with tert-butyl hydroperoxide produces singlet molecular oxygen.
Di Mascio P; Briviba K; Sasaki ST; Catalani LH; Medeiros MH; Bechara EJ; Sies H
Biol Chem; 1997 Sep; 378(9):1071-4. PubMed ID: 9348119
[TBL] [Abstract][Full Text] [Related]
19. Protective mechanisms against peptide and protein peroxides generated by singlet oxygen.
Morgan PE; Dean RT; Davies MJ
Free Radic Biol Med; 2004 Feb; 36(4):484-96. PubMed ID: 14975451
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
